Millions in Africa and the rest of the developing world suffer from HIV/AIDS, malaria, and tuberculosis. What is the best way to treat them? Since President George W. Bush's pledge of $15 billion to fight these diseases, controversy has developed over strategies and methods. Last month at a conference in Botswana, delegates wrestled with the issue of fixed-dose combinations of anti-retroviral drugs, which have not been approved by the Food and Drug Administration but were "pre-qualified" by the World Health Organization. Are such drugs safe? Or does their use risk the development of new resistant strains of HIV? Activists have accused drug companies, with the support of the Bush administration, of trying to block the use of cheaper generics, but new research indicates that only a small fraction of drugs in the developing world is patented. This conference will focus on ways that policymakers should confront the obstacles to treating pandemic diseases in the developing world.
What's new on AEI
|Rebuilding American defense: A speech by Governor Bobby Jindal|
|Smelling liberal, thinking conservative|
|Stopping Ebola before it turns into a pandemic|
|All too many reasons for pessimism about Europe|
We welcome you to join us for a panel discussion of the undersea military competition occurring in Asia and what it means for the United States and its allies.
AEI’s Election Watch is back! Please join us for two sessions of the longest-running election program in Washington, DC.
We welcome you to join us at AEI for a discussion of what’s next for the Common Core.
Please join AEI for a discussion examining each candidate’s platform and prospects for victory and the impact that a possible shift toward free-market policies in Brazil might have on South America as a whole.